NEK6 and cardiac hypertrophy: We further demonstrated that the absence of Nek6 promoted cardiac hypertrophy, fibrosis, dilatation and cardiac dysfunction, which was accompanied by the significant activation of Akt/GSK-3β signaling in an experimental model of TAC.